NeOnc Technologies (Nasdaq: NTHI) Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity Mar 4, 2026 9:00 AM EST Click here for webcast
NeOnc Technologies (Nasdaq: NTHI) Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity Mar 4, 2026 9:00 AM EST Click here for webcast